Molecular genetics of radiographically defined de novo glioblastoma multiforme

Neuropathology and Applied Neurobiology

Volumn 26, Issue 6, 2000, Pages 544-552

  Tortosa, A ^a   Ino, Y ^a,b   Odell, N ^a   Swilley, S ^a   Sasaki, H ^a,b   Louis, D N ^a,b   Henson, J W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CDKN2A p16; De novo glioblastoma; EGFR; Genetics; Glioblastoma multiforme; P53; PTEN

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CANCER GRADING; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; GENE AMPLIFICATION; GENE MUTATION; GENETIC PARAMETERS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NEURORADIOLOGY; PRIORITY JOURNAL; TEMPORAL LOBE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FRAMESHIFT MUTATION; GENE DELETION; GLIOBLASTOMA; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUTATION, MISSENSE; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TOMOGRAPHY, X-RAY COMPUTED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034526611     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2000.00290.x     Document Type: Article

References (27)

1. Human gliomas with wild-type p53 express bcl-2
2. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
3. PTEN mutations in gliomas and glioneuronal tumors
4. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme
5. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
6. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
7. Amplification of epidermal growth factor receptor gene in gliomas: Histopathology and prognosis
8. The new WHO classificaction of brain tumours
9. Primary and secondary glioblastomas: From concept to clinical diagnosis
10. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
11. A molecular genetic model of astrocytoma histopathology
12. A tiger behind many doors: Multiple genetic pathways to malignant glioma
13. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens
14. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens
15. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations
16. Genetic alterations associated with the evolution and progression of astrocytic brain tumors
17. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices
18. p53 mutation versus E.G.F. receptor expression in giant cell glioblastomas
19. Low-grade gliomas
20. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression
21. Age-dependent rate of anaplastic transformation in low-grade astrocytoma
22. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas
23. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas
24. CDKN2/p 16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
25. Subsets of glioblastoma multiforme defined by molecular genetic analysis
26. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas